Blood-derived APLP1+ extracellular vesicles as biomarkers for brain diseases
Author Information
Author(s): Choi Yuri, Park Jae Hyun, Jo Ala, Lim Chul-Woo, Park Ji-Min, Hwang Jin Woo, Lee Kang Soo, Kim Young-Sang, Lee Hakho, Moon Jisook
Primary Institution: Department of Biotechnology, College of Life Science, CHA University, Gyeonggi-do, Republic of Korea.
Hypothesis
Can APLP1+ extracellular vesicles from blood serve as reliable biomarkers for the early diagnosis of brain diseases?
Conclusion
APLP1+ extracellular vesicles from blood can be used as noninvasive biomarkers for the early diagnosis of neurodegenerative diseases.
Supporting Evidence
- APLP1+ EVs were confirmed to be of cerebral origin through RNA expression patterns.
- Validation with Thy-1 GFP M line mice demonstrated coexpression of APLP1 and GFP in brain-derived EVs.
- APLP1+ EVs showed significant enrichment in glioblastoma patient samples compared to healthy controls.
Takeaway
Scientists found a new way to detect brain diseases early by looking for special proteins in tiny bubbles in the blood.
Methodology
The study involved isolating APLP1+ extracellular vesicles from human sera and validating their brain-specific origin through various assays.
Potential Biases
Potential bias in the selection of biomarkers and the reliance on specific animal models for validation.
Limitations
The study primarily focused on APLP1 and did not explore other potential biomarkers in depth.
Participant Demographics
Included patients with glioblastoma multiforme and healthy volunteers.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website